A Phase II Study of Lenalidomide for Previously Untreated Deletion (del) 5q Acute Myeloid Leukemia (AML) Patients Age 60 or Older Who Are Not Candidates for Remission Induction Chemotherapy (Southwest Oncology Group Study S0605)

作者:Sekeres Mikkael A; Gundacker Holly; Lancet Jeffrey; Advani Anjali; Petersdorf Stephen; Liesveld Jane L; Mulford Deborah; Norwood Tom; Willman Cheryl L; List Alan F; Appelbaum Frederick R
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19